About
Portfolio
News
Contact
Contact us
Join Us
News
News
2024.12.12
Wugen to Initiate a Pivotal Trial for Its Investigational, Off-the-Shelf, Allogeneic, CD7...
2024.12.12
Wugen to Initiate a Pivotal Trial for Its Investigational, Off-the-Shelf, Allogeneic, CD7...
view more
2024.12.06
Neurelis Presents Studies On Seizure Clusters At The American Epilepsy Society Annual M...
2024.12.06
Neurelis Presents Studies On Seizure Clusters At The American Epilepsy Society Annual M...
view more
2024.12.05
Wugen to Present Clinical Data at the 2024 ASH Annual Meeting Ahead of Pivotal Trial La...
2024.12.05
Wugen to Present Clinical Data at the 2024 ASH Annual Meeting Ahead of Pivotal Trial La...
view more
2024.11.15
Neurelis Enters $208 Million Agreement to Monetize Intravail Royalties
2024.11.15
Neurelis Enters $208 Million Agreement to Monetize Intravail Royalties
view more
2024.11.12
Wugen to Initiate a Pivotal Trial for Its Investigational, Off-the-Shelf, Allogeneic, CD7...
2024.11.12
Wugen to Initiate a Pivotal Trial for Its Investigational, Off-the-Shelf, Allogeneic, CD7...
view more
2024.11.07
Onchilles Pharma Presents New Preclinical Data for the Systemically Delivered NEU-002 Pr...
2024.11.07
Onchilles Pharma Presents New Preclinical Data for the Systemically Delivered NEU-002 Pr...
view more
1
2
3
4
5
6
7
8
...
13
14